Marshall Wace LLP acquired a new stake in Azul S.A. (NYSE:AZUL – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 52,107 shares of the company’s stock, valued at approximately $87,000.
Other institutional investors have also recently bought and sold shares of the company. Trellis Wealth Advisors LLC bought a new position in shares of Azul in the 4th quarter worth $32,000. Arrowstreet Capital Limited Partnership acquired a new position in shares of Azul during the 4th quarter worth about $42,000. Inspire Advisors LLC increased its stake in shares of Azul by 16.6% in the 4th quarter. Inspire Advisors LLC now owns 48,168 shares of the company’s stock valued at $80,000 after acquiring an additional 6,844 shares during the last quarter. Van ECK Associates Corp raised its position in shares of Azul by 16.3% in the 4th quarter. Van ECK Associates Corp now owns 63,338 shares of the company’s stock valued at $106,000 after acquiring an additional 8,899 shares during the period. Finally, Raymond James Financial Inc. bought a new position in Azul during the 4th quarter worth approximately $117,000. Institutional investors and hedge funds own 0.82% of the company’s stock.
Azul Stock Performance
Shares of Azul stock opened at $0.71 on Wednesday. The firm has a market cap of $299.74 million, a PE ratio of -0.10 and a beta of 1.88. The business’s 50 day simple moving average is $1.51 and its 200 day simple moving average is $2.00. Azul S.A. has a 52-week low of $0.48 and a 52-week high of $6.64.
Wall Street Analyst Weigh In
View Our Latest Research Report on Azul
About Azul
Azul SA, together with its subsidiaries, provides air transportation services in Brazil and internationally. As of December 31, 2023, the company operated approximately 1,000 daily departures to 160 destinations through a network of 300 non-stop routes with an operating fleet of 183 aircraft and a passenger contractual fleet of 189 aircraft.
Featured Stories
- Five stocks we like better than Azul
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Why is the Ex-Dividend Date Significant to Investors?
- The Top-Ranked Insider Buys From April by Market Cap
- How to Most Effectively Use the MarketBeat Earnings Screener
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Azul Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azul and related companies with MarketBeat.com's FREE daily email newsletter.